State of Illinois
92nd General Assembly
Legislation

   [ Search ]   [ PDF text ]   [ Legislation ]   
[ Home ]   [ Back ]   [ Bottom ]


[ Engrossed ][ House Amendment 001 ][ House Amendment 002 ]
[ Senate Amendment 001 ][ Senate Amendment 002 ]


92_SB1276

 
                                               LRB9201226RCcd

 1        AN ACT in relation to pharmaceutical assistance.

 2        Be it enacted by the People of  the  State  of  Illinois,
 3    represented in the General Assembly:

 4        Section   5.   The  Senior  Citizens and Disabled Persons
 5    Property Tax Relief  and  Pharmaceutical  Assistance  Act  is
 6    amended by changing Section 3.15 as follows:

 7        (320 ILCS 25/3.15) (from Ch. 67 1/2, par. 403.15)
 8        Sec.  3.15.   "Covered prescription drug" means (1) a any
 9    cardiovascular agent  or  drug;  (2)  any  insulin  or  other
10    prescription   drug   used  in  the  treatment  of  diabetes,
11    including syringe and needles used to administer the insulin;
12    (3) any prescription drug used in the treatment of arthritis,
13    (4) beginning on January 1, 2001, any prescription drug  used
14    in the treatment of cancer, (5) beginning on January 1, 2001,
15    any  prescription  drug  used in the treatment of Alzheimer's
16    disease, (6) beginning on January 1, 2001,  any  prescription
17    drug  used  in  the  treatment  of  Parkinson's  disease, (7)
18    beginning on January 1, 2001, any prescription drug  used  in
19    the  treatment  of  glaucoma, and (8) beginning on January 1,
20    2001, any prescription drug used in  the  treatment  of  lung
21    disease  and  smoking related illnesses.  The specific agents
22    or products to be included under  such  categories  shall  be
23    listed  in  a handbook to be prepared  and distributed by the
24    Department.  The general types of covered prescription  drugs
25    shall  be  indicated by rule. The Department of Public Health
26    shall promulgate a list of covered prescription  drugs  under
27    this program that meet the definition of a narrow therapeutic
28    index drug as described in subsection (f) of Section 4.
29    (Source: P.A. 91-699, eff. 1-1-01.)

[ Top ]